Home Newsfeeds Fennec Pharmaceuticals Granted FDA Approval For PEDMARK

Fennec Pharmaceuticals Granted FDA Approval For PEDMARK

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212937

byBenzinga Newsdesk

September 20, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212937

Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

By Avi Kapoor

June 7, 8:22 AM

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Friday. Shares…

BBCP

C3.ai Beats Q4 Estimates: Stock Sells Off, Analysts Weigh In

By AJ Fabino

June 1, 11:49 AM

Enterprise artificial intelligence company C3.ai Inc (NYSE:AI) issued its fourth-quarter earnings on Wednesday, beating Street estimates with a…

BMO Capital Maintains Outperform on Sleep Country Canada, Raises Price Target to C$34

By Benzinga Newsdesk

March 6, 8:36 AM

BMO Capital analyst Stephen MacLeod maintains Sleep Country Canada (TSX:ZZZ) with a Outperform and raises the price target from C$28 to C$34.

TSX:ZZZ

Ethereum Co-Founder Vitalik Buterin Says Trading Bots Just The Start Of AI Transforming Crypto ‘This Use Case Has Existed For A Long Time’

By Mehab Qureshi

January 31, 1:12 AM

Ethereum (CRYPTO: ETH) co-founder, Vitalik Buterin, on Tuesday shed light on the potential integration of artificial intelligence (AI) with cryptocurrency.

ETH

Fennec Pharmaceuticals Granted FDA Approval For PEDMARK

Related Posts

Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

C3.ai Beats Q4 Estimates: Stock Sells Off, Analysts Weigh In

BMO Capital Maintains Outperform on Sleep Country Canada, Raises Price Target to C$34

Ethereum Co-Founder Vitalik Buterin Says Trading Bots Just The Start Of AI Transforming Crypto ‘This Use Case Has Existed For A Long Time’